AnnualReportAI — Business Intelligence
UnitedHealth Group Inc. company mark

UnitedHealth Group Inc. Annual Report FY2026

Official PDF · AI Summary · Financial Analysis
Official Annual + Quarterly Filings · AI Business Intelligence
NASDAQ/NYSE: UNH
Sector: Healthcare
Industry: Healthcare Plans
Source: SEC EDGAR
Last Updated: 09 Jun 2026
Business Intelligence Report Verdict
High
Outlook: Positive

Quality Scores

Latest Quarterly Earnings Summary

No quarterly summary available yet.

You're seeing about 10% of this report

Unlock the full 22-section intelligence dossier for UnitedHealth Group Inc.

All 21 scores, fair value models, forensic red-flag audit, management promise tracker, AI chat and PDF.

Executive Intelligence Brief

The business in brief
  • UnitedHealth Group (UNH) has demonstrated exceptional long-term compounding, growing revenue from $184.8B in 2016 to over $447B in 2025.
  • The company operates a unique dual-engine model where Optum (health services) provides high-margin diversification against the cyclicality of UnitedHealthcare (insurance).
  • Despite significant legal and impairment headwinds in 2024-2025, including the South America divestiture and Change Healthcare cyberattack impacts, the core business remains fundamentally robust.
What changed in FY2026
  • Over the last decade, UNH has successfully transitioned from a traditional health insurer into a diversified healthcare technology and service powerhouse.
  • The evolution is marked by the massive scaling of Optum, which now contributes a significant portion of total revenue and a majority of earnings growth.
What management is saying
  • Management has transitioned smoothly through several leadership changes, maintaining a consistent focus on 'value-based care' and technological integration.
  • The leadership team demonstrates deep experience in navigating the complex US regulatory environment and CMS (Centers for Medicare & Medicaid Services) reimbursement shifts.
Financial highlights
  • UNH's revenue growth is classified as 'Excellent,' maintaining a double-digit CAGR over the decade fueled by both organic growth and strategic acquisitions like Change Healthcare and LHC Group.
  • Operating margins remained stable near 8-9% until the 2024-2025 period, where statutory net income was pressured by a $7B charge related to the Brazil business sale and regulatory headwinds.

Full chapters continue in the complete report.

Valuation engine
  • Multi-model fair value computed
  • Fair value range & margin of safety
Forensic integrity
  • Beneish M-Score: Safe zone
  • Altman Z-Score: Safe zone
  • 10 structural traps scanned
Red flags & risks
  • 3 red flags documented
  • 6 auditor checks run
  • 10 risks ranked by severity
Guidance delivery
  • 3 management promises tracked
  • 10 growth drivers identified

16 more proprietary scores

Report owners
Competitive Position
Business Risks
Structural Traps
Consistency
Auditor Trust
Balance Sheet
Business Evolution
Earnings Quality
Subsidiary Value
Financial Quality
Business Evolution
Capital Allocation
Capital Efficiency
Management Quality
Management Incentive Alignment
Shareholder Alignment

Major Opportunities

  • Consistent double-digit revenue growth over 10 years
  • Optum segment continues to diversify revenue away from insurance premiums
  • Dominant market share in Medicare Advantage
  • Strong historical Cash Conversion ratios until 2023
  • Massive scale allows for industry-leading cost advantages

Major Risks

  • Significant net income deterioration in 2024-2025
  • Vulnerability to large-scale cyberattacks (Change Healthcare incident)
  • Rising Medical Care Ratio (MCR) impacting insurance profitability
  • Massive non-recurring charge from Brazil operations exit
  • Heavy reliance on government reimbursement rates (CMS)

Included in the Full Report

This brief shows only the highlights. Unlock the complete analysis:

Business Model & Segments
Competitive Advantage (Moat)
Capital Allocation
Corporate Governance
Cash Flow Quality
10-Year Financial Trends
Quality & Compounder Scores
Multi-Model Valuation
Peer Comparison
Risk Deep Dive
Management Track Record
Downloadable PDF Report

About This Annual Report

The UnitedHealth Group Inc. FY2026 Annual Report is the company's flagship annual disclosure, filed with SEC EDGAR. It covers the full-year business review, management discussion & analysis (MD&A), audited financial statements, director's report, corporate governance report, auditor's report, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This page consolidates the official PDF and an AI-generated summary so investors can quickly grasp what changed vs. prior years — sales growth, margin trend, cash flow quality, capex, dividends and management outlook — without having to read the entire filing.

Why Use AI?

  • Summarises hundreds of pages into a focused executive briefing
  • Identifies year-on-year key changes automatically
  • Extracts management commentary and tone
  • Highlights top risks and opportunities
  • Compares business evolution vs. earlier years
  • Answers your questions in plain English via Ask AI

Frequently Asked Questions

Related Research

AI Top Insights — Premium

Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.